Suppr超能文献

支气管扩张症患者的细菌定植:微生物学模式及危险因素

Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors.

作者信息

Angrill J, Agustí C, de Celis R, Rañó A, Gonzalez J, Solé T, Xaubet A, Rodriguez-Roisin R, Torres A

机构信息

Unitat de Vigilància Intensiva Respiratoria, Servei de Pneumologia, Institut Clínic de Pneumologia I Cirurgia Toràcica, Universitat de Barcelona, Villarroel 170, E-08036 Barcelona, Spain.

出版信息

Thorax. 2002 Jan;57(1):15-9. doi: 10.1136/thorax.57.1.15.

Abstract

BACKGROUND

A study was undertaken to investigate the incidence, diagnostic yield of non-invasive and bronchoscopic techniques, and risk factors of airway colonisation in patients with bronchiectasis in a stable clinical situation.

METHODS

A 2 year prospective study of 77 patients with bronchiectasis in a stable clinical condition was performed in an 800 bed tertiary university hospital. The interventions used were pharyngeal swabs, sputum cultures and quantitative protected specimen brush (PSB) bacterial cultures (cut off point > or =10(2) cfu/ml) and bronchoalveolar lavage (BAL) (cut off point > or =10(3) cfu/ml).

RESULTS

The incidence of bronchial colonisation with potential pathogenic microorganisms (PPMs) was 64%. The most frequent PPMs isolated were Haemophilus influenzae (55%) and Pseudomonas spp (26%). Resistance to antibiotics was found in 30% of the isolated pathogens. When the sample was appropriate, the operative characteristics of the sputum cultures were similar to those obtained with the PSB taken as a gold standard. Risk factors associated with bronchial colonisation by PPMs in the multivariate analysis were: (1) diagnosis of bronchiectasis before the age of 14 years (odds ratio (OR)=3.92, 95% CI 1.29 to 11.95), (2) forced expiratory volume in 1 second (FEV1) <80% predicted (OR=3.91, 95% CI 1.30 to 11.78), and (3) presence of varicose or cystic bronchiectasis (OR=4.80, 95% CI 1.11 to 21.46).

CONCLUSIONS

Clinically stable patients with bronchiectasis have a high prevalence of bronchial colonisation by PPMs. Sputum culture is a good alternative to bronchoscopic procedures for evaluation of this colonisation. Early diagnosis of bronchiectasis, presence of varicose-cystic bronchiectasis, and FEV1 <80% predicted appear to be risk factors for bronchial colonisation with PPMs.

摘要

背景

开展了一项研究,以调查临床状况稳定的支气管扩张症患者气道定植的发生率、非侵入性和支气管镜检查技术的诊断率以及危险因素。

方法

在一家拥有800张床位的三级大学医院对77例临床状况稳定的支气管扩张症患者进行了为期2年的前瞻性研究。采用的干预措施包括咽拭子、痰培养和定量保护性标本刷(PSB)细菌培养(临界值≥10²cfu/ml)以及支气管肺泡灌洗(BAL)(临界值≥10³cfu/ml)。

结果

潜在致病微生物(PPM)支气管定植的发生率为64%。分离出的最常见PPM是流感嗜血杆菌(55%)和假单胞菌属(26%)。在30%的分离病原体中发现了抗生素耐药性。当样本合适时,痰培养的操作特征与以PSB作为金标准获得的特征相似。多变量分析中与PPM支气管定植相关的危险因素为:(1)14岁之前诊断为支气管扩张症(比值比(OR)=3.92,95%可信区间1.29至11.95),(2)一秒用力呼气量(FEV1)<预测值的80%(OR=3.91,95%可信区间1.30至11.78),以及(3)存在静脉曲张型或囊状支气管扩张(OR=4.80,95%可信区间1.11至21.46)。

结论

临床状况稳定的支气管扩张症患者中PPM支气管定植的患病率很高。痰培养是评估这种定植的支气管镜检查程序的良好替代方法。支气管扩张症的早期诊断、静脉曲张型 - 囊状支气管扩张的存在以及FEV1<预测值的80%似乎是PPM支气管定植的危险因素。

相似文献

2
3
Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
Arch Intern Med. 2005 Apr 25;165(8):891-7. doi: 10.1001/archinte.165.8.891.
4
Bacterial colonisation of lower airways in health and chronic lung disease.
Clin Respir J. 2008 Apr;2(2):116-22. doi: 10.1111/j.1752-699X.2008.00048.x.
6
Sputum bacteriology in steady-state bronchiectasis in Guangzhou, China.
Int J Tuberc Lung Dis. 2015 May;19(5):610-9. doi: 10.5588/ijtld.14.0613.
8
Microbiologic follow-up study in adult bronchiectasis.
Respir Med. 2007 Aug;101(8):1633-8. doi: 10.1016/j.rmed.2007.03.009. Epub 2007 Apr 30.
10
A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
Ann Am Thorac Soc. 2014 May;11(4):496-503. doi: 10.1513/AnnalsATS.201310-335OC.

引用本文的文献

1
Short-term Tolerance to Inhaled Antibiotics in Patients With Bronchial Infection not Associated With Cystic Fibrosis.
Open Respir Arch. 2025 Jun 24;7(3):100460. doi: 10.1016/j.opresp.2025.100460. eCollection 2025 Jul-Sep.
2
A Clinical Study on Microbiological Profile in Tracheostomy Wounds.
Indian J Otolaryngol Head Neck Surg. 2024 Jun;76(3):2411-2416. doi: 10.1007/s12070-024-04507-z. Epub 2024 Feb 3.
3
Is there a role for lung or bronchial biopsies for the diagnosis of mycobacterial pulmonary disease in patients with bronchiectasis?
J Clin Tuberc Other Mycobact Dis. 2024 Apr 25;36:100447. doi: 10.1016/j.jctube.2024.100447. eCollection 2024 Aug.
5
Microbiome features in bronchoalveolar lavage fluid of patients with idiopathic inflammatory myopathy-related interstitial lung disease.
Front Med (Lausanne). 2024 Apr 3;11:1338947. doi: 10.3389/fmed.2024.1338947. eCollection 2024.
8
South African Thoracic Society position statement on the management of non-cystic fibrosis bronchiectasis in adults: 2023.
Afr J Thorac Crit Care Med. 2023 Aug 3;29(2). doi: 10.7196/AJTCCM.2023.v29i2.647. eCollection 2023.
9
Resistance patterns of bacterial pathogens causing lower respiratory tract infections: Aleppo-Syria.
Ann Med Surg (Lond). 2023 May 8;85(6):2655-2661. doi: 10.1097/MS9.0000000000000778. eCollection 2023 Jun.

本文引用的文献

1
Bacteriologic flora of the lower respiratory tract.
N Engl J Med. 1961 Dec 28;265:1273-8. doi: 10.1056/NEJM196112282652601.
3
An investigation into causative factors in patients with bronchiectasis.
Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1277-84. doi: 10.1164/ajrccm.162.4.9906120.
5
Determinants of chronic infection with Staphylococcus aureus in patients with bronchiectasis.
Eur Respir J. 1999 Dec;14(6):1340-4. doi: 10.1183/09031936.99.14613409.
9
Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation.
Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1498-505. doi: 10.1164/ajrccm.157.5.9711044.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验